SHZ:002864
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd · SHZ · Healthcare · CNY · FY for 2025
Figures on this page computed 2026-11-08 13:30 UTC
Last close
n/aCNY
Market data
21.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2025
13.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
8.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
1.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.07Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
What it pays out is the furthest below its sector's middle: 0.28 against 0.54 on the market's range.
Follow one yuan
lens 1 of 9The five stops
5 of 5 read- After what it costs to make591,789,47951.9%
- After running the business110,120,6229.7%
- After interest and tax96,279,4048.4%
- After what it must reinvest20,604,6631.8%
- Kept after the dividend-23,289,405-2.0%
Of every unit of sales, -0.02 is still there after the dividend.
Of every unit of sales, -0.02 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales1,140,869,253
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After what it costs to make591,789,479
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After running the business110,120,622
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After interest and tax96,279,404
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
After what it must reinvest20,604,663
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Kept after the dividend-23,289,405
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY